Healthcare -
Biotechnology - NASDAQ - US
$ 7.45
-2.24 %
$ 1.21 B
Market Cap
2.54
P/E
NVAX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities NVAX - Novavax, Inc.
-204 M
LAST VALUE
-48.13%
2 YEAR CAGR
-44.50%
5 YEAR CAGR
-4.62%
10 YEAR CAGR